Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) was up 4.9% during mid-day trading on Tuesday . The company traded as high as $0.37 and last traded at $0.37. Approximately 249 shares were traded during trading, a decline of 85% from the average daily volume of 1,705 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Stock Performance
The firm has a 50-day moving average price of $0.44 and a 200-day moving average price of $0.43.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Featured Articles
- Five stocks we like better than Zelira Therapeutics
- Why is the Ex-Dividend Date Significant to Investors?
- 3 Stocks With Rising Prices That Are Likely to Split in 2025
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Why Adobe Stock Could Be the Best Dip Buy in Tech Right Now
- How to Calculate Options Profits
- Short-Squeeze Target Anavex Life Sciences Gains Traction
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
